sulfisoxazole has been researched along with probenecid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Benet, LZ; Gloff, CA; Mamelok, RD | 1 |
| Breschi, LC; Shapiro, SR | 1 |
| Cohen, M; Pocelinko, R | 1 |
| Cohen, MR | 1 |
| Jarrell, JP; O'Dell, RM; Schlegel, JU | 1 |
| Caldwell, JL | 1 |
| Ali, MA; Billing, BH | 1 |
1 review(s) available for sulfisoxazole and probenecid
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
14 other study(ies) available for sulfisoxazole and probenecid
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Organic anion transport by basal-lateral membranes: effect of PAH and furosemide on each other's transport.
Topics: Aminohippuric Acids; Animals; Binding, Competitive; Biological Transport, Active; Furosemide; In Vitro Techniques; Kidney; Membranes; p-Aminohippuric Acid; Probenecid; Rabbits; Sulfisoxazole | 1988 |
Venereal disease in Vietnam: clinical experience at a major military hospital.
Topics: Aerospace Medicine; Anti-Bacterial Agents; Benzalkonium Compounds; Chancroid; Condylomata Acuminata; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Gonorrhea; Granuloma Inguinale; Herpesviridae Infections; Hospitals, Special; Humans; Lymphogranuloma Venereum; Male; Molluscum Contagiosum; Podophyllin; Probenecid; Sexually Transmitted Diseases; Sulfisoxazole; Syphilis; United States; Urethritis; Vietnam | 1974 |
Renal transport mechanisms for the excretion of sulfisoxazole.
Topics: Animals; Bicarbonates; Dogs; Female; Glomerular Filtration Rate; Humans; Hydrogen-Ion Concentration; Kidney; Probenecid; Protein Binding; Sodium; Sulfisoxazole; Tablets, Enteric-Coated; Time Factors | 1973 |
Renal handling of N4-acetylsulfisoxazole (NAS).
Topics: Animals; Biological Transport, Active; Dogs; Glomerular Filtration Rate; Kidney; Kidney Tubules; Metabolic Clearance Rate; Probenecid; Sulfisoxazole | 1973 |
Renal distrubution of sulfisoxazole in canine kidney.
Topics: Animals; Chlorphenesin; Dehydration; Dogs; Glomerular Filtration Rate; Kidney; Probenecid; Sulfisoxazole | 1969 |
Actinomycosis treated with cephalothin.
Topics: Actinomycosis, Cervicofacial; Adult; Cephalothin; Female; Humans; Hydrocortisone; Infusions, Parenteral; Nystatin; Penicillins; Prednisone; Probenecid; Sulfisoxazole | 1971 |
Renal excretion of bilirubin by the rat.
Topics: Aminohippuric Acids; Animals; Bile Acids and Salts; Bilirubin; Diuresis; Kidney; Kidney Glomerulus; Male; Probenecid; Protein Binding; Rats; Sodium Salicylate; Sulfisoxazole | 1968 |